Spero Therapeutics's market cap is currently ―. The company's EPS TTM is $0.423; its P/E ratio is 3.61; Spero Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 25.47M	$ 2.72M	$ 2.07M	$ 46.35M	$ 1.08M
Gross Profit	$ 25.47M	$ 2.72M	$ 2.07M	$ 47.44M	-
EBIT	$ -994.00K	$ -11.91M	$ -14.23M	$ 26.03M	$ -11.68M
EBITDA	$ -886.00K	$ -11.81M	$ -14.12M	$ 26.16M	$ -11.42M
Net Income Common Stockholders	$ -3.19M	$ -11.91M	$ -13.27M	$ 26.77M	$ -11.68M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 93.83M	$ 77.69M	$ 96.25M	$ 109.11M	$ 50.45M
Total Assets	$ 107.10M	$ 98.89M	$ 112.29M	$ 124.80M	$ 64.48M
Total Debt	$ 5.89M	$ 6.18M	$ 6.47M	$ 6.74M	$ 6.90M
Net Debt	$ -87.93M	$ -71.51M	$ -89.79M	$ -102.36M	$ -43.55M
Total Liabilities	$ 53.40M	$ 44.10M	$ 47.71M	$ 48.87M	$ 31.99M
Stockholders Equity	$ 53.70M	$ 54.74M	$ 64.88M	$ 75.93M	$ 32.48M
Cash Flow	-
Free Cash Flow	$ 15.91M	$ -18.56M	$ -12.85M	$ 44.48M	$ -957.00K
Operating Cash Flow	$ 15.91M	$ -18.56M	$ -12.85M	$ 44.48M	$ -957.00K
Investing Cash Flow	-	-	-	-	$ -129.00K
Financing Cash Flow	$ 220.00K	-	-	$ 14.18M	$ 6.13M

Currency in USD

Spero Therapeutics Earnings and Revenue History

Income Statement >

Spero Therapeutics Debt to Assets

Balance Sheet >

Spero Therapeutics Cash Flow

Cash Flow >

Spero Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing